Vivo Capital, LLC
Filing Date
Global Rank
#1,622
/ 8,622
▼ 10
· as of Mar 2026
Top Industry
Biotechnology
99.6%
3Y Alpha vs SPY
+15.6%
Period ended 4 months ago
Filed May 20, 2026 · 2mo
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Cloned portfolio
+143.2%
SPY
+67.9%
Annualised alpha
+15.6%
Max drawdown
−36.8%
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
44 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
16.9%
−0.6 pts
Top 5
42.3%
+0.9 pts
Top 10
61.3%
+1.2 pts
HHI
596
Diversified−2
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,164,469,705 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
5 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ERAS | Erasca, Inc. | +2,878,052 | 12,151,480 | $196,610,946 | |
| CRVS | Corvus Pharmaceuticals, Inc. | +571,250 | 2,805,816 | $41,049,088 | |
| DBVT | DBV Technologies S.A. | +205,943 | 2,667,569 | $55,725,516 | |
| DRUG | Bright Minds Biosciences Inc. | +55,555 | 557,172 | $40,656,840 | |
| PRAX | Praxis Precision Medicines, Inc. | +10,000 | 338,895 | $109,188,580 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GERN | Geron Corp | −18,553,495 | 8,671,797 | $12,920,977 | |
| TERN | Terns Pharmaceuticals, Inc. | −4,012,510 | 1,334,418 | $70,350,516 | |
| ACRS | Aclaris Therapeutics, Inc. | −2,222,222 | 6,666,666 | $24,999,997 | |
| COGT | Cogent Biosciences, Inc. | −1,976,693 | 422,300 | $16,254,327 | |
| DYN | Dyne Therapeutics, Inc. | −1,057,494 | 1,557,466 | $28,236,858 | |
| VRDN | Viridian Therapeutics, Inc.\DE | −816,288 | 166,288 | $3,252,593 | |
| SLNO | Soleno Therapeutics Inc | −600,000 | 294,909 | $9,873,553 | |
| ORIC | Oric Pharmaceuticals, Inc. | −269,598 | 1,848,786 | $23,424,118 | |
| ABVX | Abivax S.A. | −119,766 | 239,539 | $26,672,667 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| FTH | Faeth Therapeutics, Inc. | 722,020 | $22,758,070 | |
| AVBP | ArriVent BioPharma, Inc. | 885,916 | $20,438,082 | |
| MANE | Veradermics, Inc | 300,000 | $18,945,000 | |
| ANTX | AN2 Therapeutics, Inc. | 3,153,640 | $10,785,448 | |
| OKUR | OnKure Therapeutics, Inc. | 1,927,710 | $7,980,719 | |
| ALXO | Alx Oncology Holdings Inc | 3,184,713 | $6,385,349 | |
| MSLE | Satellos Bioscience Inc. | 813,666 | $4,580,939 | |
| CMPS | COMPASS Pathways plc | 200,000 | $1,106,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | 853,495 | $30,990,403 | |
| CTMX | CytomX Therapeutics, Inc. | 2,884,615 | $12,288,459 | |
| ABEO | Abeona Therapeutics Inc. | 1,842,751 | $9,711,297 | |
| VSTM | Verastem, Inc. | 1,106,524 | $8,542,365 | |
| SLN | Silence Therapeutics plc | 1,105,454 | $6,721,160 | |
| PALI | Palisade Bio, Inc. | 2,293,578 | $5,389,908 | |
| No positions match the current search. | ||||
44 tracked positions ·
$1,164,469,705 total
· filing declares
46 positions · $1,202,954,264
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 12,151,480 | $196,610,946 | 16.88% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 338,895 | $109,188,580 | 9.38% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,334,418 | $70,350,516 | 6.04% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 5,094,668 | $60,779,389 | 5.22% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
Added | 2,667,569 | $55,725,516 | 4.79% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Held | 9,545,466 | $50,495,515 | 4.34% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Held | 2,154,780 | $45,077,997 | 3.87% | |
| SABS |
SAB Biotherapeutics, Inc.
Healthcare
|
Held | 11,420,000 | $43,738,600 | 3.76% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Added | 2,805,816 | $41,049,088 | 3.53% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 557,172 | $40,656,840 | 3.49% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Held | 353,998 | $29,707,512 | 2.55% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 1,557,466 | $28,236,858 | 2.42% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 239,539 | $26,672,667 | 2.29% | |
| NERV |
Minerva Neurosciences, Inc.
Healthcare
|
Held | 4,322,747 | $26,044,550 | 2.24% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Reduced | 6,666,666 | $24,999,997 | 2.15% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,848,786 | $23,424,118 | 2.01% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
Held | 1,035,551 | $23,279,186 | 2.00% | |
| FTH |
Faeth Therapeutics, Inc.
Healthcare
|
NEW | 722,020 | $22,758,070 | 1.95% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
NEW | 885,916 | $20,438,082 | 1.76% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Held | 800,000 | $19,728,000 | 1.69% | |
| MANE |
Veradermics, Inc
Healthcare
|
NEW | 300,000 | $18,945,000 | 1.63% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
Held | 4,246,568 | $18,727,364 | 1.61% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Held | 1,000,000 | $18,640,000 | 1.60% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Held | 1,612,903 | $17,161,287 | 1.47% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 422,300 | $16,254,327 | 1.40% | |
| GERN |
Geron Corp
Healthcare
|
Reduced | 8,671,797 | $12,920,977 | 1.11% | |
| UNCY |
Unicycive Therapeutics, Inc.
Healthcare
|
Held | 1,789,916 | $11,777,647 | 1.01% | |
| ANTX |
AN2 Therapeutics, Inc.
Healthcare
|
NEW | 3,153,640 | $10,785,448 | 0.93% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Held | 671,843 | $10,017,179 | 0.86% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 294,909 | $9,873,553 | 0.85% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Held | 1,350,000 | $9,774,000 | 0.84% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
NEW | 1,927,710 | $7,980,719 | 0.69% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Held | 260,000 | $7,573,800 | 0.65% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
NEW | 3,184,713 | $6,385,349 | 0.55% | |
| MNPR |
Monopar Therapeutics
Healthcare
|
Held | 90,500 | $4,958,495 | 0.43% | |
| MSLE |
Satellos Bioscience Inc.
Healthcare
|
NEW | 813,666 | $4,580,939 | 0.39% | |
| PEPG |
PepGen Inc.
Healthcare
|
Held | 2,325,000 | $4,115,250 | 0.35% | |
| SERA |
Sera Prognostics, Inc.
Healthcare
|
Held | 1,650,440 | $3,350,393 | 0.29% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Held | 208,333 | $3,331,244 | 0.29% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Reduced | 166,288 | $3,252,593 | 0.28% | |
| TIL |
Instil Bio, Inc.
Healthcare
|
Held | 292,743 | $2,412,202 | 0.21% | |
| KTTA |
Pasithea Therapeutics Corp.
Healthcare
|
Held | 2,100,000 | $1,558,200 | 0.13% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
NEW | 200,000 | $1,106,000 | 0.09% | |
| DTIL |
Precision Biosciences Inc
Healthcare
|
Held | 4,675 | $25,712 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.